Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

86results about How to "Maintain normal flow" patented technology

Catalyzed SCR filter and emission treatment system

Provided is an emission treatment system and method for simultaneously remediating the nitrogen oxides (NOx), particulate matter, and gaseous hydrocarbons present in diesel engine exhaust streams. The emission treatment system has an oxidation catalyst upstream of a soot filter coated with a material effective in the Selective Catalytic Reduction (SCR) of NOx by a reductant, e.g., ammonia. Also provided is a method for disposing an SCR catalyst composition on a wall flow monolith that provides adequate catalyst loading, but does not result in unsuitable back pressures in the exhaust.
Owner:BASF CORP

Catalyzed SCR filter and emission treatment system

Provided is an emission treatment system and method for simultaneously remediating the nitrogen oxides (NOx), particulate matter, and gaseous hydrocarbons present in diesel engine exhaust streams. The emission treatment system has an oxidation catalyst upstream of a soot filter coated with a material effective in the Selective Catalytic Reduction (SCR) of NOx by a reductant, e.g., ammonia. Also provided is a method for disposing an SCR catalyst composition on a wall flow monolith that provides adequate catalyst loading, but does not result in unsuitable back pressures in the exhaust.
Owner:BASF CORP

Apparatus and Method of Use for an Adjustable Radial and Ulnar Compression Wristband

ActiveUS20150018869A1Rapidly removeSufficient adjustable compressionTourniquetsAngiographyVascular compressionMedical procedure
An adjustable radial and ulnar vascular compression wristband assists in achieving partial or full occlusion of a blood vessel when applied to a patient's wrist during or following a medical procedure. At least two adjustably inflatable non-adjacent balloons on the wristband apply preferential compression to portions of the circumference of the wrist, including in particular those portions overlying the ulnar and radial arteries.
Owner:SEMLER TECH

Method of Manufacturing Tissue Sealing Electrodes

The present disclosure relates to an electrode assembly for use with an electrosurgical instrument. The electrode assembly includes a pair of opposing jaw members and an electrode positioned on each jaw member. One or both of the electrodes includes a tissue contacting surface that has an outer periphery and defines a side surface depending therefrom. The tissue contacting surface and the side surface include a conjoining edge formed at a first predetermined angle that defines a first linear transition zone dimensioned to reduce arcing between the opposing jaw members during activation of the electrosurgical instrument.
Owner:TYCO HEALTHCARE GRP LP

Microfluidic system and methods

A microfluidic system comprising: at least one microfluidic channel, the inner surface of which is fluorinated or fluorous; and a pump for supplying a flow of an aqueous medium containing chemical reagents or assay components to said microfluidic channel. Preferably, the apparatus further comprises a supply of a non-aqueous medium which is compatible with the surface of the microfluidic channel but immiscible with the aqueous medium, such as a perfluorocarbon solvent, for forming a sheath around the flowing aqueous medium whereby the aqueous medium is suspended away from the surface of the microfluidic channel. Also provided are methods for carrying out a chemical reaction or a biological assay in the microfluidic systems of the subject matter disclosed herein.
Owner:SCIEX

Flux injection assembly and method

A flux injector apparatus and method adapted to distribute a predetermined amount of flux to an associated pool of molten aluminum. The flux injector apparatus includes a pressurized tank adapted to store and feed the flux under pressure. A feed mechanism operative to discharge a predetermined amount of flux to an outlet and a controller for monitoring and operating the apparatus. The feed mechanism includes a housing having an inner wall defining a cavity with an inlet and an outlet. A feed wheel is positioned within the cavity and operative to receive a predetermined amount of flux from the inlet, translate the flux within the cavity and discharge the predetermined amount of flux through the outlet of the pressurized tank.
Owner:PYROTECK INC

Process for generating electric energy, steam and carbon dioxide from hydrocarbon feedstock

A process producing electric energy, steam and carbon dioxide in concentrated form from a hydrocarbon feedstock. The process includes forming synthesis gas in an air driven autothermal reactor unit (ATR), heat exchanging the formed synthesis gas and thereby producing steam, treating at least part of the synthesis gas in a CO-shift reactor unit and carbon dioxide separation unit for formation of concentrated carbon dioxide and a lean hydrogen containing gas which is combusted in a combined cycle gas turbine for production of electric energy, and where air from the turbine is supplied to the ATR unit. The exhaust from the gas turbine is heat exchanged for the production of steam which together with steam generated upstream said unit is utilized in a power generator for production of substantially CO2-free electric energy. Steam may be fed to the gas turbine for diluting the hydrogen containing gas mixture. The process may also be combined with the production of synthesis gas products such as methanol and / or ammonia. Part of the gas from the carbon dioxide removal unit may be utilized in a fuel cell.
Owner:STATOIL ASA PETRO SA (NO)

Methods and systems for screening subjects

InactiveUS20120302909A1Improve exercise capacityImprove function capacityRespiratory organ evaluationSensorsTest agentScreening method
A screening method can be used to determine whether a subject is a suitable candidate for interventional therapy. The method can be used to determine the likelihood the subject will receive a therapeutic effect from denervation therapy. The determination is based, at least in part, on lung information obtained by performing lung function tests with and without treating the subject's lungs with a test agent. Based on the response to a test agent, the subject's response to a therapy is predicted.
Owner:NUVAIRA INC

Enhanced DOCSIS upstream channel changes

Enhanced DOCSIS upstream channel changes. A CMTS directs channel changing of a CM, sometimes between upstream data bursts. Logical channels, part of a single frequency channel, may be used, and the channel changing may be performed between those logical channels. Multiple upstream burst profiles and / or modulation densities may be used providing high degrees of robustness, fidelity, and throughput and allowing great channel flexibility. A CM may be switched between channels without losing transmitter capability. Even if some throughput rate may be sacrificed during the channel changing, the CM will still be able to continue data throughput. Then, the new channel may then undergo the initialization and ranging processes thereby enabling greater throughput on that new channel. After undergoing the initialization and ranging processes, the new channel will then be a fully equivalent member of the CM communication system.
Owner:AVAGO TECH INT SALES PTE LTD

Method of manufacturing tissue sealing electrodes

The present disclosure relates to an electrode assembly for use with an electrosurgical instrument. The electrode assembly includes a pair of opposing jaw members and an electrode positioned on each jaw member. One or both of the electrodes includes a tissue contacting surface that has an outer periphery and defines a side surface depending therefrom. The tissue contacting surface and the side surface include a conjoining edge formed at a first predetermined angle that defines a first linear transition zone dimensioned to reduce arcing between the opposing jaw members during activation of the electrosurgical instrument.
Owner:TYCO HEALTHCARE GRP LP

Laser ablation cell

A laser ablation cell (1) comprises a flow channel (11) having an essentially constant cross-sectional area so as to ensure a strictly laminar flow in the flow channel. A sample chamber (21) is provided adjacent to a lateral opening (14) of the flow channel. A laser beam (41) enters the sample chamber (21) through a lateral window (16) and impinges on a surface (24) of a sample (23) to ablate material from the sample. The sample may be positioned in such a distance from the flow channel that the laser-generated aerosol mass distribution has its center within the flow channel. This leads to short aerosol washout times. The laser ablation cell is particularly well suited for aerosol generation in inductively coupled plasma mass spectrometry (ICPMS), including imaging applications.
Owner:ETH ZZURICH +1

Infusion Catheter Tip for Biologics with Reinforced External Balloon Valve

A system for moving particles suspended in a first fluid, and for infusing them into the stream of a second fluid, includes a catheter with a multi-lumen distal separator. The separator is formed with a plurality of parallel lumens, wherein each lumen has a predetermined diameter to reduce particle flocculation. An inflatable balloon, affixed to the outside of the catheter, can be provided to regulate flow of the second fluid and thereby facilitate entry of the particles into the stream of the second fluid. A reinforcing member is employed to strengthen the catheter wall under the inflatable balloon. With this arrangement, the catheter does not kink or collapse due to the pressure exerted on the catheter wall when the balloon is inflated. In one embodiment, the reinforcing member includes an annular shaped ring. In another embodiment, the separator is positioned under the balloon and acts as the reinforcing member.
Owner:COOK REGENTEC

Kit and devices for organ perfusion

InactiveUS20150018597A1Reducing operative traumaReduce operating proceduresBalloon catheterOther blood circulation devicesMedicineOrgan blood flow
The present invention provides a kit for the delivery a therapeutic agent to an organ blood flow and the removal of the excess of said therapeutic agent from said organ blood flow, said kit comprises: (a) the therapeutic agent, (b) a first retrievable medical device (26), for delivering said therapeutic agent into the organ inflow, (c) a second retrievable medical device for isolating the organ outflow vessel and (d) a separation device (25) comprising at least one filter able to separate the therapeutic agent excess from the organ outflow, having an inlet (38) for the organ outflow having a therapeutic agent excess and an outlet (39) for filtered organ outflow.
Owner:MEDICAL DEVICE WORKS NV

Vascular Compression Apparatus, Pad and Method Of Use

ActiveUS20120053617A1Reducing and stopping blood flowDecreased blood flowTourniquetsSurgeryVascular compression
An adjustable vascular compression device assists in achieving partial or full occlusion of a blood vessel when applied to a patient's limb, for example, during or following a medical procedure. Pads on the device apply preferential compression to portions of the circumference of the limb so as to enable blood flow through adjacent blood vessels during the compression period. Further, rapid fastening, tightening, loosening and release is enabled by a single mechanism, and gradual adjustments to the tightness may be made without releasing said mechanism.
Owner:SEMLER TECH

Mask configured to maintain nutrient transport without producing visible diffraction patterns

ActiveUS20060079960A1Increase depth of focusEliminate DiffractionSpectales/gogglesSenses disorderAnterior surfaceCorneal layer
A mask configured to be implanted in a cornea of a patient to increase the depth of focus of the patient includes an anterior surface, a posterior surface, and a plurality of holes. The anterior surface is configured to reside adjacent a first corneal layer. The posterior surface is configured to reside adjacent a second corneal layer. The plurality of holes extends at least partially between the anterior surface and the posterior surface. The holes of the plurality of holes are configured to substantially eliminate visible diffraction patterns.
Owner:ACUFOCUS

Heart pump apparatus and method for beating heart surgery

InactiveUS20090112049A1Maintaining cardiac outputAvoid the needIntravenous devicesBlood pumpVeinSuperior vena cava
Apparatus for assisting a surgeon in procedures involving the heart and methods of employing such apparatus are provided. The apparatus can include a pump, and a first fluid conduit having a distal end adapted to be inserted into the superior vena cava of a beating heart, a second fluid conduit having a distal end adapted to be inserted into the inferior vena cava, and a third fluid conduit having a distal end adapted to be inserted into the pulmonary artery of the beating heart, each in liquid fluid communication with the pump, which in combination can be operatively positioned to form a closed cardiac pathway extending from the vena cavae and to the pulmonary artery to thereby convey blood collected from the vena cavae into the pulmonary artery, operatively bypassing the right side of the heart. The pump is positioned to both convey blood flow from each vena cavae and to the third fluid conduit and to provide a blood reservoir which enables the provision of manual assistance to the blood flow to the lungs when blood flow is insufficient.
Owner:SAUDI ARABIAN OIL CO

Combination Double-Barreled and Debranching Stent Grafts and Methods for Use

ActiveUS20140172064A1Maintain blood flowMore benefitStentsBlood vesselsStent graftingCardiology
A combination double-barreled and debranching stent graft and methods for its use, where the stent graft comprises, a main body stent graft defining a single lumen with distal and proximal ends, a first bifurcation in the main body defining first and second lumens, the main body stent graft defines a tubular wall that is contiguous with the first and second lumens such that any fluid entering the main body stent graft must exit by entering one of the first or second lumens, (c) a second bifurcation within the first lumen defining a first leg and a second leg, (d) a third bifurcation within the first leg defining a third leg and a fourth leg, and (e) a fourth bifurcation within the second leg between about 10 mm and about 20 mm distal from the second bifurcation defining a fifth leg and a sixth leg.
Owner:SANFORD HEALTH

Enhanced channel changing within multi-channel communication systems

Enhanced channel changing within multi-channel communication systems. A CMTS directs channel changing of a CM, sometimes between upstream data bursts. Logical channels, part of a single frequency channel, may be used, and the channel changing may be performed between those logical channels. Multiple upstream burst profiles and / or modulation densities may be used providing high degrees of robustness, fidelity, and throughput and allowing great channel flexibility. A CM may be switched between channels without losing transmitter capability. Even if some throughput rate may be sacrificed during the channel changing, the CM will still be able to continue data throughput. Then, the new channel may then undergo the initialization and ranging processes thereby enabling greater throughput on that new channel. After undergoing the initialization and ranging processes, the new channel will then be a fully equivalent member of the CM communication system.
Owner:AVAGO TECH INT SALES PTE LTD

High-lift, low drag fin for surfboard and other watercraft

This invention discloses a fin, for use on a surfboard and other watercraft, of a low-drag, high-lift, high-aspect-ratio, low-sweepback-angle planform of symmetrical foil section, with a fit root section that has a forwardly projecting leading edge and cutaway at the trailing edge, alone or in combination with winglets placed on the vertical fin element so as to minimize tip-vortex drag, so as to make the surfboard or watercraft more maneuverable, easier to propel through the water, and to stabilize the surfboard or watercraft.
Owner:WAVEGRINDER

Debranching Visceral Stent Graft and Methods for Use

ActiveUS20130274851A1Maintaining blood flowIncrease surgical optionStentsBlood vesselsStent graftingMedicine
A debranching visceral stent graft and methods for its use, where the stent graft comprises, a main body stent graft with a bifurcation defining a first leg and a second leg, the main body stent graft has a distal end and a proximal end, the main body stent graft's diameter at the proximal end ranges from about 18-22 mm, the first leg and the second leg each have a diameter that ranges from about 14-16 mm, the distance from the proximal end of the main body to the distal end of the first leg ranges from about 70-90 mm, the distance from the proximal end of the main body to the distal end of the second leg ranges from about 80-100 mm, and the second leg is at least about 10 mm longer than the first leg.
Owner:SANFORD HEALTH

Apparatus For An Adjustable Radial And Ulnar Compression Wristband

ActiveUS20180028195A1Sufficient adjustable compressionMaintain normal flowTourniquetsVascular compressionBlood vessel
An adjustable radial and ulnar vascular compression wristband assists in achieving partial or full occlusion of a blood vessel when applied to a patient's wrist during or following a medical procedure. At least two adjustably inflatable non-adjacent balloons on the wristband apply preferential compression to portions of the circumference of the wrist, including in particular those portions overlying the ulnar and radial arteries.
Owner:SEMLER TECH

Debranching visceral stent graft and methods for use

A debranching visceral stent graft and methods for its use, where the stent graft comprises, a main body stent graft with a bifurcation defining a first leg and a second leg, the main body stent graft has a distal end and a proximal end, the main body stent graft's diameter at the proximal end ranges from about 18-22 mm, the first leg and the second leg each have a diameter that ranges from about 14-16 mm, the distance from the proximal end of the main body to the distal end of the first leg ranges from about 70-90 mm, the distance from the proximal end of the main body to the distal end of the second leg ranges from about 80-100 mm, and the second leg is at least about 10 mm longer than the first leg.
Owner:SANFORD HEALTH

Debranching Stent Graft Limb and Methods for Use

InactiveUS20130274861A1Maintain blood flowIncrease surgical optionStentsBlood vesselsStent graftingAnatomy
A debranching stent graft limb and methods for its use, where the limb comprises, a main body stent graft limb with a bifurcation defining a first and second leg, the main body stent graft limb has a distal end and a proximal end, the main body stent graft limb has a diameter at the proximal end in the range from about 14-18 mm, the first leg has a diameter ranging from about 8-12 mm, the second leg has a diameter ranging from about 6-10 mm, and the distance from the proximal end of the main body to the distal end of the first leg and the second leg is in the range from about 70-90 mm, and the diameter of the first leg is about 2 mm greater than the diameter of the second leg.
Owner:SANFORD HEALTH

Combination Double-Barreled and Debranching Stent Grafts and Methods for Use

ActiveUS20160287376A1Maintain blood flowIncrease optionStentsBlood vesselsCardiologyStent grafting
A combination double-barreled and debranching stent graft and methods for its use, where the stent graft comprises, a main body stent graft defining a single lumen with distal and proximal ends, a first bifurcation in the main body defining first and second lumens, the main body stent graft defines a tubular wall that is contiguous with the first and second lumens such that any fluid entering the main body stent graft must exit by entering one of the first or second lumens, (c) a second bifurcation within the first lumen defining a first leg and a second leg, (d) a third bifurcation within the first leg defining a third leg and a fourth leg, and (e) a fourth bifurcation within the second leg between about 10 mm and about 20 mm distal from the second bifurcation defining a fifth leg and a sixth leg.
Owner:SANFORD HEALTH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products